Page 29 - Sumit Chanda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Print Scientists at the Sanford Burnham Prebys Medical Discovery Institute in La Jolla have identified a set of human genes that fight SARS-CoV-2, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body’s frontline virus fighters. “We wanted to gain a better understanding of the cellular response to SARS-CoV-2, including what drives a strong or weak response to infection...

By Nancy Lapid April 19 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Physical inactivity tied to higher COVID-19 risks Patients with COVID-19 who have been consistently physically inactive have a significantly higher risk of severe outcomes than patients who were getting at least some exercise or regularly met physical activity guidelines prior to the illness, researchers found. Among the 48,440 patients in their study, 14.4% were consistently ...

Physical inactivity tied to higher COVID-19 risk; new trial attempts to reinfect virus survivors Reuters 1 hr ago By Nancy Lapid (Reuters) -The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Physical inactivity tied to higher COVID-19 risks Patients with COVID-19 who have been consistently physically inactive have a significantly higher risk of severe outcomes than patients who were getting at least some exercise or regularly met physical activity guidelines ...

A team of researchers, including one of Indian-origin, has suggested that a leprosy drug holds promise as an at-home treatment for Covid-19.The study showed that the leprosy drug clofazimine exhibits potent antiviral activities against ...

 E-Mail IMAGE: Sumit Chanda, co-senior study author and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys. view more  Credit: Sanford Burnham Prebys Medical Discovery Institute LA JOLLA, CALIF. - March 16, 2021 - A Nature study authored by scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization's List of Essential Medicines, exhibits potent antiviral activities against SARS-CoV-2 and prevents the exaggerated inflammat...